tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kelechi Chikere, 11 are a BUY (91.67%), 1 are a HOLD (8.33%).
Analyst Kelechi Chikere, currently employed carries an average stock price target met ratio of 41.67% that have a potential upside of 49.06% achieved within 39 days.
Kelechi Chikere’s has documented 21 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ALT, Altimmune at 29-Dec-2021.
Analyst best performing recommendations are on ALT (ALTIMMUNE).
The best stock recommendation documented was for ALT (ALTIMMUNE) at 12/23/2020. The price target of $24 was fulfilled within 56 days with a profit of $11.38 (90.17%) receiving and performance score of 16.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$12
$4.39 (57.69%)
$12
7 days ago
(14-Nov-2024)
0/12 (0%)
$3.12 (35.14%)
Buy
$20
$12.39 (162.81%)
$20
3 months 9 days ago
(12-Aug-2024)
4/16 (25%)
$13.78 (221.54%)
214
Buy
$25
$17.39 (228.52%)
$25
5 months ago
(21-Jun-2024)
3/13 (23.08%)
$18.59 (290.02%)
42
Buy
$24
$16.39 (215.37%)
$16
6 months 11 days ago
(10-May-2024)
0/13 (0%)
$16.78 (232.41%)
Hold
$26
6 months 23 days ago
(29-Apr-2024)
0/5 (0%)
$12.36 (90.62%)
What Year was the first public recommendation made by Kelechi Chikere?
